Lyell Immunopharma Inc
LYEL
$8.16-0.37%
Delayed · as of Oct 16, 2026, 2:00 PM ET
Mkt cap
$143.49M
EV/Sales
2314.2
P/E ratio
N/A
FY2025 Revenue
$36,000
EPS (TTM)
$-12.69
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-762355.56%
Beta
-0.27
Div yield
N/A
Sector
Healthcare
Lyell Immunopharma Inc (LYEL) is a biotechnology company listed on US.
Latest reported LYEL revenue for 2025-12-31 was $36.0K. Net income was -$274.4M. Revenue was down 41.0% from 2024-12-31 to 2025-12-31. LYEL currently screens at market cap $143.5M.
Use this LYEL research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full LYEL income, balance, and cash tables.
Lyell Immunopharma Inc (LYEL) is a biotechnology company in the Healthcare sector.
Latest cached Lyell Immunopharma Inc (LYEL) revenue for Dec 31, 2025 was $36.0K. Net income was -$274.4M. Statements: https://lician.com/financials/lyel
Lyell Immunopharma Inc (LYEL) market capitalization is $143.5M on the latest cached snapshot.
Lyell Immunopharma Inc (LYEL) cached previous close $8.19; day range $8.16 – $8.24; volume 71,414. Session quote: https://lician.com/quote/lyel
Lyell Immunopharma Inc (LYEL) latest cached earnings event is "LYEL earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached LYEL filing is 8-K · Sep 10, 2026. Filings: https://lician.com/sec/lyel